Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven I Sherman

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
Thyroid : Official Journal of the American Thyroid Association|January 20, 2006
Management guidelines for patients with thyroid nodules and differentiated thyroid cancerDavid S Cooper, Gerard M Doherty, Bryan R Haugen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2014
Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experienceRamona Dadu, Komal Shah, Naifa L Busaidy, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 11, 2003
Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationshipLinwah Yip, Gilbert J Cote, Suzanne E Shapiro, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2006
Phase II study of celecoxib in metastatic differentiated thyroid carcinomaEwa Mrozek, Richard T Kloos, Matthew D Ringel, et al.
JNCI Cancer Spectrum|September 13, 2024
Glycemic control in diabetic patients improved overall lung cancer survival across diverse populationsWayne Y Wu, Brian Luke, Xiao-Cheng Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2016
Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid CancerJian Yu Xu, Beverly Handy, Christina L Michaelis, et al.
Molecular Cancer Therapeutics|February 4, 2021
ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of <i>RET</i>, <i>VEGFR2</i>, and <i>IGFBP2</i>Rozita Bagheri-Yarmand, Ramona Dadu, Lei Ye, et al.
The Journal of Clinical Endocrinology and Metabolism|November 28, 2012
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoringAubrey A Carhill, Maria E Cabanillas, Camilo Jimenez, et al.
Head & Neck|April 11, 2009
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinomaGary L Clayman, Thomas D Shellenberger, Lawrence E Ginsberg, et al.
Cancer|April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
Thyroid : Official Journal of the American Thyroid Association|January 20, 2006
Management guidelines for patients with thyroid nodules and differentiated thyroid cancerDavid S Cooper, Gerard M Doherty, Bryan R Haugen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2014
Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experienceRamona Dadu, Komal Shah, Naifa L Busaidy, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 11, 2003
Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationshipLinwah Yip, Gilbert J Cote, Suzanne E Shapiro, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2006
Phase II study of celecoxib in metastatic differentiated thyroid carcinomaEwa Mrozek, Richard T Kloos, Matthew D Ringel, et al.
JNCI Cancer Spectrum|September 13, 2024
Glycemic control in diabetic patients improved overall lung cancer survival across diverse populationsWayne Y Wu, Brian Luke, Xiao-Cheng Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2016
Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid CancerJian Yu Xu, Beverly Handy, Christina L Michaelis, et al.
Molecular Cancer Therapeutics|February 4, 2021
ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of <i>RET</i>, <i>VEGFR2</i>, and <i>IGFBP2</i>Rozita Bagheri-Yarmand, Ramona Dadu, Lei Ye, et al.
The Journal of Clinical Endocrinology and Metabolism|November 28, 2012
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoringAubrey A Carhill, Maria E Cabanillas, Camilo Jimenez, et al.
Head & Neck|April 11, 2009
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinomaGary L Clayman, Thomas D Shellenberger, Lawrence E Ginsberg, et al.
Cancer|April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
Pageof 16